Jobs / United States / Novartis Pharmaceuticals Corporation
Associate Director Science & Technology (m/f/d)
Novartis Pharmaceuticals Corporation · 🇺🇸 Schaftenau
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Novartis Pharmaceuticals Corporation paid sponsored hires in similar roles2 certified filings for “Director - Decision Science, Immunology Product Lead” (Molecular and Cellular Biologists) in NJ: $96k–$138k, median $117k. Most were filed at wage level II (50%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Novartis Pharmaceuticals Corporation
The US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Novartis Pharmaceuticals Corporation →
About the role
Salary Range: €88,300.00 - €164,100.00 Job Description Summary With the increasing diversity of Novartis' portfolio, the need for drug-device combination product analytical data packages is also increasing. As such, we are searching for a Senior Expert - Medical Device Analytical Representative with combination product development experience to lead the creation of strong analytical data-packages. As a member of the global Chemistry Manufacturing Control (CMC) analytical sub team and device sub team for your project(s) you will be the main contact & coordinator for all project-specific analytical tasks related to functional attributes of drug-device combination products at all levels (from component to drug product to final product), especially for injectables like Biologics, Ribonucleic Acids, Radio-Ligands (peptides) in e.g. a prefilled syringe in a autoinjector or needle-safety-device. #LI-Hybrid Location - Schaftenau, Austria Job Description Key Responsibilities: • As a member of global CMC analytical subteam and device subteam for your project(s), you are the contact person & coordinator for all project-specific analytical tasks related to functional/mechanical attributes of drug-device combination products at all levels (from component to drug product to final product); plan resource & budget for your project(s). • Select testing laboratory inline with resource availability, capability and in/outsourcing strategy, e.g. GDPD, QC, CRO; lead outsourced analytical project activities at CROs and contribute to manage external partnership. • Own drug-specific analytical methods (AMs) / parameter sheets (PSs) for functional attributes like activation and injection force, time, volume, sound, as well as (needle) safety features, organize and align x-functional inputs (e.g. with Device/Pack Tech); define, organize, document AM/PS validation and transfer. • Co-shape and co-author x-functional analytical CMC strategies and documents, e.g. drug product and final product stability strategy, protocols and reports, method validation and transfer status summaries, Analytical Specifications (AS); organize input to Justification of Specification JoS (from Device/PackTech and HFE). • Contribute to and review regulatory documents, support product registrations with a minimal support by Leader or assigned to moderately complex projects. • Performs statistical data analysis using statistical tools (e.g. Minitab) to generate and justify device related specifications for clinical and commercial setup. Essential Requirements: • Master or PhD in engineering or chemical/bio analytics or equivalent and minimum 5 years’ experience and strong knowledge in (parenteral) Combination Product Development or related area (e.g. Manufacturing, Regulatory, QA) • Proven knowledge in late phase parenteral analytical development; leadership experience in managing development projects, ideally in a global matrix environment, understanding and awareness of regulatory guidelines for combination. product analytics, experience with cGMP and relevant ISOs • Collaborative spirit, self-driven attitude, high level of learning agility. • Proficiency in English (written and spoken). Rewards : In addition to a market-competitive base salary, we offer an attractive incentive program, a modern company pension scheme, childcare facilities, learning and development opportunities as well as worldwide career possibilities within the Novartis group. In accordance with Austrian law, we are obliged to disclose the minimum salary as stated in the collective bargaining agreement. For this position the minimum salary is € 78,383.90 EUR/year (on a full-time basis). The actual salary will be significantly higher, as we strive to maintain a competitive position in the market